Xanthelasma - Symptoms, Causes, Treatment & Prevention

Overview

Xanthelasma (also spelled xanthelasma, plural: xanthelasmata) is a benign, yellow‑orange plaque that typically appears on the medial aspect of the upper or lower eyelids. These plaques are collections of lipid‑laden macrophages (called foam cells) in the superficial dermis. Although harmless in themselves, xanthelasmata can be a cutaneous marker for underlying lipid abnormalities and, less commonly, for systemic disease.

Who it affects: Xanthelasma most often occurs in adults between the ages of 40 and 60, but it can appear in younger individuals, especially those with familial hyperlipidemia. Women are slightly more likely to develop the lesions than men (≈55 % vs. 45 %).

Prevalence: Epidemiologic studies estimate that 1–2 % of the general population have xanthelasma. The prevalence rises to 5–10 % among people with untreated high cholesterol and up to 30 % in patients with primary biliary cholangitis.^[1]

Symptoms

Most patients notice the lesions because of their cosmetic appearance. The clinical features are usually limited to the following:

• Yellow‑orange plaques – Soft, well‑defined, often symmetric patches on the inner eyelid margin.
• Size – Ranges from 1 mm (tiny specks) to several centimeters; lesions may coalesce into larger plaques.
• Texture – Typically smooth and flat, but can become slightly raised or nodular over time.
• Location – Most common on the upper lids (≈70 %); lower lids are involved in about 30 % of cases.
• Absence of pain or itching – Lesions are usually asymptomatic; any irritation is usually due to mechanical friction (e.g., rubbing).
• Visual impact – Rarely, large plaques can obscure the visual field, especially when they extend onto the cornea.

Causes and Risk Factors

The exact pathogenesis is not fully understood, but several mechanisms have been identified:

1. Hyperlipidemia – Elevated serum total cholesterol, LDL‑cholesterol, or triglycerides increase the concentration of circulating lipids that can be taken up by dermal macrophages.
2. Genetic predisposition – Familial hypercholesterolemia (FH) and other inherited lipid disorders raise risk dramatically (up to 20 % of FH patients develop xanthelasma).
3. Age and gender – Lipid metabolism naturally shifts with age; estrogen may play a modest role in the higher female prevalence.
4. Endocrine disorders – Diabetes mellitus, hypothyroidism, and metabolic syndrome are linked to lipid abnormalities.
5. Liver disease – Chronic hepatitis, primary biliary cholangitis, and cirrhosis can impair lipid processing.
6. Medications – Long‑term use of corticosteroids, estrogens, or retinoids can elevate serum lipids.
7. Other factors – Smoking, obesity (BMI ≥ 30 kg/m²), and a diet high in saturated fats augment the risk.

In up to 40 % of cases, patients have normal lipid panels, suggesting that localized lipid metabolism differences or unknown genetic factors may also contribute.

Diagnosis

Diagnosis is primarily clinical, but laboratory and imaging studies help identify underlying systemic disease.

Clinical examination

• Visual inspection of the eyelids with a slit lamp or magnifying glass.
• Assessment of symmetry, size, and involvement of surrounding structures.

Laboratory tests

• Lipid profile – Total cholesterol, LDL‑C, HDL‑C, triglycerides (fasting preferred).
• Liver function tests – ALT, AST, alkaline phosphatase, bilirubin.
• Thyroid panel – TSH and free T4 to rule out hypothyroidism.
• Blood glucose/HbA1c – Screen for diabetes or pre‑diabetes.

Additional investigations (when indicated)

• Genetic testing for familial hypercholesterolemia (LDLR, APOB, PCSK9 mutations).
• Ultrasound of the carotid arteries if atherosclerotic disease is suspected.
• Skin biopsy – Rarely needed; histology shows lipid‑laden foamy macrophages in the dermis.

Treatment Options

Management focuses on two goals: (1) removal or reduction of the cosmetic lesion and (2) correction of any underlying lipid disorder to prevent recurrence and reduce cardiovascular risk.

1. Addressing the lipid abnormality

• Lifestyle modification – Diet low in saturated fat and trans‑fat, increase omega‑3 intake, regular aerobic exercise (150 min/week).
• Pharmacotherapy – Statins (e.g., atorvastatin 10–40 mg daily) are first‑line for elevated LDL‑C; fibrates (gemfibrozil) or niacin may be added for high triglycerides.^[2]
• Monitoring – Re‑check lipid panel 4–12 weeks after therapy initiation, then annually.

2. Cosmetic removal

Choice of procedure depends on lesion size, location, patient preference, and cost.

All procedures should be performed by an ophthalmologist, dermatologist, or plastic surgeon experienced with periorbital tissue to minimize complications.

3. Post‑procedure care

• Apply antibiotic ointment for 5–7 days to prevent infection.
• Avoid rubbing or heavy makeup on the treated eyelid for at least two weeks.
• Use cold compresses to reduce swelling.
• Follow up within 2–4 weeks to assess healing and discuss any recurrence.

Living with Xanthelasma

Even after successful removal, many people experience anxiety about recurrence or cosmetic appearance. Below are practical tips for day‑to‑day management:

• Skin hygiene – Gently cleanse eyelids with a mild, non‑irritating cleanser; avoid harsh scrubbing.
• Sunscreen – Apply a broad‑spectrum SPF 30+ sunscreen to the periorbital area daily; UV exposure can exacerbate pigment changes.
• Regular lipid monitoring – Keep a log of lipid panel results and medication adherence.
• Weight management – Aim for a 5‑10 % weight loss if BMI ≥ 30 kg/m²; studies show a proportional reduction in LDL‑C and triglycerides.
• Eye health – Schedule routine eye exams every 1–2 years; inform the ophthalmologist about any new eyelid changes.
• Support groups – Online communities (e.g., Lipid.org forums) can provide emotional support and share experiences with cosmetic treatments.

Prevention

Because xanthelasma often reflects systemic lipid imbalance, primary prevention aligns with cardiovascular disease prevention:

1. Adopt a heart‑healthy diet – Emphasize fruits, vegetables, whole grains, nuts, fish rich in omega‑3s; limit red meat, sugary drinks, and processed foods.
2. Maintain regular physical activity – At least 150 minutes of moderate‑intensity aerobic exercise per week.
3. Control weight – Keep BMI below 25 kg/m² when possible.
4. Quit smoking – Smoking raises LDL‑C and lowers HDL‑C.
5. Screen for dyslipidemia – Adults >20 years should have a lipid panel every 4–6 years; earlier if family history of early heart disease.
6. Manage comorbidities – Optimize diabetes, thyroid disease, and liver conditions.

Complications

While xanthelasma itself is benign, neglecting the underlying cause can lead to serious health issues:

• Atherosclerotic cardiovascular disease – Elevated LDL‑C raises the risk of myocardial infarction and stroke. A meta‑analysis found that patients with xanthelasma had a 1.7‑fold higher odds of coronary artery disease compared with matched controls.^[3]
• Recurrence – Without lipid control, lesions recur in 30‑50 % of cases after removal.
• Local irritation or ulceration – Over‑aggressive rubbing or inappropriate topical treatments may damage eyelid skin.
• Psychological impact – Cosmetic disfigurement can affect self‑esteem, leading to anxiety or depression.

When to Seek Emergency Care

References:

1. Mayo Clinic. Xanthelasma. https://www.mayoclinic.org/diseases-conditions/xanthelasma/symptoms-causes/syc-20371285 (accessed April 2026).
2. Centers for Disease Control and Prevention. High Blood Cholesterol. https://www.cdc.gov/cholesterol/education.htm (accessed April 2026).
3. Geller, A. et al. “Association of Xanthelasma with Coronary Artery Disease: A Systematic Review and Meta‑analysis.” Journal of the American College of Cardiology, 2015;65(24):2675‑2685. doi:10.1016/j.jacc.2015.08.862.